Arcutis Biotherapeutics Inc Earnings

Arcutis Biotherapeutics Inc’s revenue jumped 81.48% since last year same period to $129.5Mn in the Q4 2025. On a quarterly growth basis, Arcutis Biotherapeutics Inc has generated 30.52% jump in its revenue since last 3-months.

Arcutis Biotherapeutics Inc’s net profit jumped 261.24% since last year same period to $17.4Mn in the Q4 2025. On a quarterly growth basis, Arcutis Biotherapeutics Inc has generated 134.75% jump in its net profits since last 3-months.

Arcutis Biotherapeutics Inc’s net profit margin jumped 188.85% since last year same period to 13.43% in the Q4 2025. On a quarterly growth basis, Arcutis Biotherapeutics Inc has generated 79.85% jump in its net profit margins since last 3-months.

Arcutis Biotherapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.04 - a -145.15% fall from last quarter’s estimates.

Arcutis Biotherapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.04.

Arcutis Biotherapeutics Inc’s earning per share (EPS) jumped 244.44% since last year same period to 0.13 in the Q4 2025. This indicates that the Arcutis Biotherapeutics Inc has generated 244.44% annual rate of jump in its earning per share (EPS) in the last 4 quarters.